Scrip Symbol
SUDARSCHEM (NSE)
Sudarshan Chemical Industries Limited has submitted a regulatory filing to BSE Limited and the National Stock Exchange of India Limited (NSE). The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.
The purpose of the filing is to intimate the exchanges about a scheduled interaction with Analysts and/or Institutional Investors. The details of the meeting are as follows:
- Date and Time: 29th June, 2026 at 11:30 A.M. Indian Standard Time (IST)
- Interacting Party: Axis Capital Limited
- Type of Meeting: In-person, One-on-One Meeting
The company included a note stating that the provided details are subject to change. Potential reasons for changes include exigencies, logistical disorders, and last-minute schedule conflicts on the part of the Analysts, Institutional Investors, or the Company itself.
The disclosure explicitly states that the Company does not intend to discuss any Unpublished Price Sensitive Information (UPSI) during these scheduled meetings.
The letter was digitally signed by Mandar Meenanath Velankar, who holds the position of General Counsel and Company Secretary for Sudarshan Chemical Industries Limited. The company's Registered Office is located at 7th Floor, Eleven West Panchshil, Survey No 25, Near PAN Card Club Road, Baner, Pune 411 069, Maharashtra, India. Its Corporate Identification Number (CIN) is L24119PN1951PLC008409.